Shao-Tzu Li
Overview
Explore the profile of Shao-Tzu Li including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
222
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yuen J, Zhou S, Caeser R, Venkatramani M, Bte Ishak D, Li S, et al.
Eur J Hum Genet
. 2025 Jan;
33(3):289-296.
PMID: 39843919
The popularity of multi-gene testing has identified more families with two or more pathogenic variants (PV) in cancer predisposition genes, also known as 'MINAS' (multilocus inherited neoplasia alleles syndromes). They...
2.
Ishak N, Shaw T, Li S, Yuen J, Goh H, Chua Z, et al.
J Genet Couns
. 2023 Oct;
33(5):985-994.
PMID: 37864575
Due to a lack of ancestry-matched, functional, and segregation data, Asians have a higher rate of receiving a variant of uncertain significance (VUS) result following panel testing. Managing VUS results...
3.
Shaw T, Fok R, Courtney E, Li S, Chiang J, Ngeow J
Singapore Med J
. 2023 Feb;
64(1):67-73.
PMID: 36722519
Genetic testing has the power to identify individuals with increased predisposition to disease, allowing individuals the opportunity to make informed management, treatment and reproductive decisions. As genomic medicine continues to...
4.
Chan S, Ni Y, Li S, Teo J, Ishak N, Lim W, et al.
JNCI Cancer Spectr
. 2022 Aug;
5(1).
PMID: 35929646
Background: Fanconi anemia (FA) is a rare genetic disorder associated with hematological disorders and solid tumor predisposition. Owing to phenotypic heterogeneity, some patients remain undetected until adulthood, usually following cancer...
5.
Chang C, Li S, Pan T, Tsai C, Wang I, Chang T, et al.
Sci Rep
. 2022 Jan;
12(1):112.
PMID: 34997104
Device quantization of in-memory computing (IMC) that considers the non-negligible variation and finite dynamic range of practical memory technology is investigated, aiming for quantitatively co-optimizing system performance on accuracy, power,...
6.
Chiang J, Chia T, Yuen J, Shaw T, Li S, Ishak N, et al.
JCO Precis Oncol
. 2022 Jan;
5:577-584.
PMID: 34994607
Purpose: Genetic testing has clinical utility in the management of patients with hereditary cancer syndromes. However, the increased likelihood of encountering a variant of uncertain significance in individuals of non-European...
7.
Sim J, Shaw T, Li S, Courtney E, Yuen J, Chiang J, et al.
J Genet Couns
. 2021 May;
30(6):1658-1670.
PMID: 33934420
Telehealth is a growing field, its pertinence magnified by COVID-19 causing the accelerated digitalization of the world. Given the significant global demand to provide telehealth services, it is important to...
8.
Cao J, Tan R, Li S, Courtney E, Goh R, Fan B, et al.
Clin Case Rep
. 2021 Feb;
9(2):995-1009.
PMID: 33598286
Timely genetic testing leading to early diagnosis of A-T is crucial due to its plethora of implications on clinical management, particularly in those who develop malignancies. Thus, clinicians have to...
9.
Chiang J, Yuen J, Shaw T, Goh H, Li S, Courtney E, et al.
Front Pediatr
. 2020 Nov;
8:568528.
PMID: 33194895
Approximately 10% of pediatric cancer patients possess germline pathogenic/likely pathogenic variants (PV/LPV) in known tumor predisposition genes. Predictive testing is the optimal approach to identify asymptomatic at-risk relatives to guide...
10.
Yuen J, Fung S, Sia C, Venkatramani M, Shaw T, Courtney E, et al.
Hered Cancer Clin Pract
. 2020 Oct;
18:22.
PMID: 33110458
Introduction: Identification of one's status as a pathogenic variant carrier often marks the start of navigating challenging decisions related to cancer risk management and result disclosure. Carriers report unmet informational...